• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重期细菌病因的预测模型。

A prediction model for bacterial etiology in acute exacerbations of COPD.

作者信息

Lode H, Allewelt M, Balk S, De Roux A, Mauch H, Niederman M, Schmidt-Ioanas M

机构信息

Helios Klinikum Emil von Behring, affiliated Free University Berlin, Chest Hospital Heckeshorn (Infectious Disease and Immunology), Zum Heckeshorn 33, 14109, Berlin, Germany.

出版信息

Infection. 2007 Jun;35(3):143-9. doi: 10.1007/s15010-007-6078-z.

DOI:10.1007/s15010-007-6078-z
PMID:17565454
Abstract

OBJECTIVES

Bacteria play a leading role in acute exacerbations of chronic obstructive pulmonary disease (COPD), but we lack predictors of bacterial etiology. We developed a prediction model for infection with gram-negative enteric bacteria (GNEB) and Pseudomonas aeruginosa.

METHODS

Clinical presentation, sputum characteristics, microbial sputum patterns, lung function and previous and concomitant medication were prospectively recorded in patients with moderate to severe exacerbation of COPD. Risk factors for a specific bacterial etiology were calculated and a prediction model developed.

RESULTS

A total of 193 patients with acute exacerbation were included. In 121 (62.6%) of them a microbial etiology could be identified, most frequently Haemophilus influenzae (32 strains), Streptococcus pneumoniae (22 strains) and P. aeruginosa (12 strains). Multivariate analysis identified severe airflow obstruction and use of systemic steroids as predictors for exacerbation due to gram-negative enteric bacilli and P. aeruginosa. A prediction model including FEV1 < 35% of predicted value, systemic steroid use and prior antibiotic therapy within preceeding 3 months had a negative predictive of 89%, being a helpful tool in excluding patients at risk of exacerbation due to gram-negative enteric bacilli and P. aeruginosa when all criteria are absent.

CONCLUSION

A simple prediction model based on three factors may identify COPD patients at low risk for exacerbations with gram-negative enteric bacilli and P. aeruginosa. Bacterial Etiology in COPD Exacerbations.

摘要

目的

细菌在慢性阻塞性肺疾病(COPD)急性加重中起主导作用,但我们缺乏细菌病因的预测指标。我们开发了一种针对革兰氏阴性肠道细菌(GNEB)和铜绿假单胞菌感染的预测模型。

方法

前瞻性记录中重度COPD急性加重患者的临床表现、痰液特征、痰液微生物模式、肺功能以及既往和同时使用的药物。计算特定细菌病因的危险因素并开发预测模型。

结果

共纳入193例急性加重患者。其中121例(62.6%)可确定微生物病因,最常见的是流感嗜血杆菌(32株)、肺炎链球菌(22株)和铜绿假单胞菌(12株)。多因素分析确定严重气流受限和全身使用类固醇是革兰氏阴性肠道杆菌和铜绿假单胞菌所致急性加重的预测指标。一个包含FEV1<预测值的35%、全身使用类固醇以及前3个月内曾使用抗生素治疗的预测模型,其阴性预测值为89%,当所有标准均不存在时,是排除革兰氏阴性肠道杆菌和铜绿假单胞菌所致急性加重风险患者的有用工具。

结论

基于三个因素的简单预测模型可识别革兰氏阴性肠道杆菌和铜绿假单胞菌所致急性加重风险较低的COPD患者。COPD急性加重中的细菌病因。

相似文献

1
A prediction model for bacterial etiology in acute exacerbations of COPD.慢性阻塞性肺疾病急性加重期细菌病因的预测模型。
Infection. 2007 Jun;35(3):143-9. doi: 10.1007/s15010-007-6078-z.
2
Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.台湾慢性阻塞性肺疾病急性加重住院患者的痰液细菌学,重点关注肺炎克雷伯菌和铜绿假单胞菌。
Respirology. 2007 Jan;12(1):81-7. doi: 10.1111/j.1440-1843.2006.00999.x.
3
Predictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病加重期痰液培养阳性的预测因素。
Respirology. 2009 Nov;14(8):1114-20. doi: 10.1111/j.1440-1843.2009.01615.x. Epub 2009 Sep 16.
4
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的微生物学决定因素
Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891.
5
Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.因慢性阻塞性肺疾病急性加重伴脓性痰住院患者的痰微生物学检查结果
Respiration. 2007;74(1):19-25. doi: 10.1159/000093158. Epub 2006 May 3.
6
Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study.慢性阻塞性肺疾病急性加重期门诊患者的细菌感染及危险因素:一项为期2年的前瞻性研究。
Respirology. 2007 Mar;12(2):283-7. doi: 10.1111/j.1440-1843.2006.01002.x.
7
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.痰液颜色作为慢性阻塞性肺疾病急性细菌感染加重的一项指标。
Respir Med. 2005 Jun;99(6):742-7. doi: 10.1016/j.rmed.2004.10.020. Epub 2004 Dec 10.
8
Bacterial exacerbations of chronic obstructive pulmonary disease. The role of lung function in aetiology of exacerbation.慢性阻塞性肺疾病的细菌感染加重。肺功能在加重病因中的作用。
Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):475-80.
9
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.新型细菌菌株与慢性阻塞性肺疾病的急性加重
N Engl J Med. 2002 Aug 15;347(7):465-71. doi: 10.1056/NEJMoa012561.
10
Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病加重期细菌感染的临床预测因素
Clin Infect Dis. 2004 Oct 1;39(7):980-6. doi: 10.1086/423959. Epub 2004 Sep 10.

引用本文的文献

1
Lung microbiome in children with hematological malignancies and lower respiratory tract infections.血液系统恶性肿瘤合并下呼吸道感染患儿的肺部微生物群
Front Oncol. 2022 Sep 21;12:932709. doi: 10.3389/fonc.2022.932709. eCollection 2022.
2
Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病中度加重期的细菌病因及肺炎球菌尿抗原
J Thorac Dis. 2022 Jul;14(7):2532-2543. doi: 10.21037/jtd-22-133.
3
Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines.
预防 COPD(AECOPD)急性加重复发的抗菌治疗:超越指南。
Respir Res. 2022 Mar 14;23(1):58. doi: 10.1186/s12931-022-01947-5.
4
IL-17 Aggravates Airway Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.IL-17 加重慢性阻塞性肺疾病急性加重期的气道感染。
Front Immunol. 2022 Jan 13;12:811803. doi: 10.3389/fimmu.2021.811803. eCollection 2021.
5
Inhaled corticosteroid dose is associated with infection in severe COPD.吸入性皮质类固醇剂量与严重 COPD 感染相关。
BMJ Open Respir Res. 2021 Oct;8(1). doi: 10.1136/bmjresp-2021-001067.
6
Impact of Infection on Patients with Chronic Inflammatory Airway Diseases.感染对慢性炎症性气道疾病患者的影响。
J Clin Med. 2020 Nov 24;9(12):3800. doi: 10.3390/jcm9123800.
7
Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者慢性支气管感染的当前挑战
J Clin Med. 2020 May 28;9(6):1639. doi: 10.3390/jcm9061639.
8
Impact of Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort.隔离对门诊慢性阻塞性肺疾病队列患者死亡率及预后的影响
Open Forum Infect Dis. 2020 Jan 4;7(1):ofz546. doi: 10.1093/ofid/ofz546. eCollection 2020 Jan.
9
Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病急性加重期细菌感染:系统评价和荟萃分析。
Infection. 2020 Feb;48(1):19-35. doi: 10.1007/s15010-019-01350-1. Epub 2019 Sep 3.
10
Personalized medicine for patients with COPD: where are we?慢性阻塞性肺疾病患者的个体化医学:我们在哪里?
Int J Chron Obstruct Pulmon Dis. 2019 Jul 9;14:1465-1484. doi: 10.2147/COPD.S175706. eCollection 2019.